02/03/2026
Bariatric Surgery vs. GLP-1RAs: Which truly delivers long-term results? 💉🆚🏥
In the era of "weight-loss jabs," is the surgical "gold standard" being challenged? A new study involving over 7,600 patients suggests that when it comes to long-term results for those with Type-2 Diabetes and obesity, the scalpel still outweighs the needle.
While GLP-1 Receptor Agonists have revolutionised metabolic care, this retrospective analysis of publicly insured patients reveals a stark difference in three-year outcomes.
The Highlights:
📈 The Weight Loss Gap: Bariatric surgery was associated with a 22.9% total body weight loss at 3 years, compared to just 2.3% for those on GLP-1RAs.
📉 Consistency Matters: Even for patients with 12 months of consecutive GLP-1RA use, surgery remained significantly more effective for sustained weight reduction.
🏥 Payer-Group Insights: This study provides crucial data for the Medicare and Medicaid population—the largest payer group in the U.S.—helping clinicians navigate treatment pathways for high-risk patients.
The Verdict: GLP-1RAs are a fantastic addition to our toolkit, but for significant and durable weight loss in this cohort, surgery remains the powerhouse intervention.
✍️ Authors: Avery Brown, Suhani S. Patel, Elizabeth Li, Alexander Hien Vu, Eduardo Somoza, Jialin Chen, Donglan Zhang, Allan B. Massie, Babak J. Orandi, Dorry Segev, Manish Parikh & Karan Chhabra
🔗 Read the full study via: https://link.springer.com/article/10.1007/s00464-025-12403-y
💡 Member Benefit: As always, EAES members can access the full article for free via our online portal!